|
Gender (women), n (%)
|
9 (18)
|
7 (18)
|
0 (0)
|
0.5
|
|
Age (years), mean ± SD
|
61.5 ± 14.8
|
60.3 ± 12.2
|
61.6 ± 12.5
|
0.7
|
|
Severe valvular dysfunction, n (%)
|
23 (46)
|
25 (64)
|
3 (50)
|
0.2
|
|
Paravalvular extension, n (%)
|
13 (26)
|
5 (13)
|
0 (0)
|
0.1
|
|
Vegetation length (mm), mean ± SD
|
7.7 ± 6.2
|
10.2 ± 7.9
|
26.3 ± 13.3
|
0.008
|
|
Second infected valve, n (%)
|
4 (8)
|
5 (13)
|
1 (17)
|
0.6
|
|
Ejection Fraction (%), mean ± SD
|
59.1 ± 8.0
|
60.9 ± 8.5
|
58.3 ± 6.6
|
0.5
|
|
TAPSE (mm), mean ± SD
|
20.8 ± 6.2
|
23.2 ± 5.3
|
21.2 ± 6.9
|
0.2
|
|
Euroscore II
|
7.3 ± 6.3
|
5.6 ± 9.1
|
4.3 ± 2.5
|
0.035
|
|
Surgery, n (%)
|
42 (84)
|
34 (87)
|
6 (100)
|
0.5
|
|
Ejection Fraction (%) at follow-up, mean ± SD
|
58.9 ± 8.3
|
55.9 ± 9.1
|
55.1 ± 11.0
|
0.2
|
|
Severe valvular dysfunction at follow-up, n (%)
|
0 (0)
|
4 (10)
|
0 (0)
|
0.03
|
